Elevated expression of UBE2T in lung cancer tumors and cell lines

Tumor Biology

Volumn 29, Issue 3, 2008, Pages 195-203

  Hao, Jia ^a   Xu, Anjian ^a   Xie, Xiaolei ^a   Hao, Juanting ^a   Tian, Tian ^a   Gao, Shugeng ^b   Xiao, Xueyuan ^a   He, Dacheng ^a,c  

^a Beijing Normal University   (China)

^b CANCER HOSPITAL   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Anchorage independent growth; Lung cancer; Tumorigenesis; UBE2T; Ubiquitin conjugating enzyme

Indexed keywords

MESSENGER RNA; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN CONJUGATING ENZYME E2T; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRONCHUS MUCOSA; CANCER CELL CULTURE; CANCER TISSUE; CELL CULTURE; COLONY FORMATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CARCINOGENESIS; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SMALL CELL CARCINOMA; TISSUE DISTRIBUTION; UPREGULATION; WESTERN BLOTTING;

EID: 48049103452     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000148187     Document Type: Article

References (19)

1. Jemal A, Siegel R, Ward E, Murray T, Xu JQ, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Osada H, Takahashi T: Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 2002;21:7421-7434.
3. Rubin DM, Finley D: Proteolysis. The proteasome: a protein-degrading organelle? Curr Biol 1995;5:854-858.
4. Reed SI: Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nat Rev Mol Cell Biol 2003;4:855-864.
5. Aguilar RC, Wendland B: Ubiquitin: not just for proteasomes anymore. Curr Opin Cell Biol 2003;15:184-190.
6. Sweder K, Madura K: Regulation of repair by the 26S proteasome. J Biomed Biotechnol 2002;2:94-105.
7. Schmidt M, Hanna J, Elsasser S, Finley D: Proteasome-associated proteins: regulation of a proteolytic machine. Biol Chem 2005;386:725-737.
8. Shekhar MP, Lyakhovich A, Visscher DW, Heng H, Kondrat N: Rad6 overexpression induces multinucleation, centrosome amplification, abnormal mitosis, aneuploidy, and transformation. Cancer Res 2002;62:2115-2124.
9. McDoniels-Silvers AL, Nimri CF, Stoner GD, Lubet RA, You M: Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 2002;8:1127-1138.
10. Okamoto Y, Ozaki T, Miyazaki K, Aoyama M, Miyazaki M, Nakagawara A: UbcH10 Is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res 2003;63:4167-4173.
11. Gordon GJ, Appasani K, Parcells JP, Mukhopadhyay NK, Jaklitsch MT, Richards WG, Sugarbaker DJ, Bueno R: Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. Carcinogenesis 2002;23:1017-1024.
12. Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G: Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness. Clin Cancer Res 2005;11:5128-5139.
13. Nanjangud G, Naresh K, Teruya-Feldstein J, Filippa D, Zelenetz A, Chaganti R: Chromosome-change-based gene expression analysis reveals differentially expressed genes/pathways associated with histologic progression and transformation in follicular lymphoma. AACR Meet Abstr 2006, pp 795-796.
14. Su WH, Chao CC, Yeh SH, Chen DS, Chen PJ, Jou YS: OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci. Nucleic Acids Res 2007;35:D727-D731.
15. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y: The new World Health Organization classification of lung tumours. Eur Respir J 2001;18:1059-1068.
16. Yokota J, Kohno T: Molecular footprints of human lung cancer progression. Cancer Sci 2004;95:197-204.
17. Machida YJ, Machida Y, Chen Y, Gurtan AM, Kupfer GM, D'Andrea AD, Dutta A: UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell 2006;23:589-596.
18. Alpi A, Langevin F, Mosedale G, Machida YJ, Dutta A, Patel KJ: UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination. Mol Cell Biol 2007;27:8421-8430.
19. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD: E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev 2002;16:245-256.